Pulmonary Arterial Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Wearable activity tracker data can be used to obtain metrics associated with user's physical health

Wearable activity tracker data can be used to obtain metrics associated with user's physical health

New guidelines recommend earlier detection and treatment of pulmonary hypertension

New guidelines recommend earlier detection and treatment of pulmonary hypertension

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

Study reveals underlying signaling pathway that results in pulmonary arterial hypertension

Study reveals underlying signaling pathway that results in pulmonary arterial hypertension

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

Role of leptin in immune modulation and pathophysiology of COVID-19

Role of leptin in immune modulation and pathophysiology of COVID-19

Platelet inhibitors may be linked with reduction in digital ulcers in people with systemic sclerosis

Platelet inhibitors may be linked with reduction in digital ulcers in people with systemic sclerosis

Researchers employ novel algorithm to identify candidate cancer drugs for pulmonary hypertension

Researchers employ novel algorithm to identify candidate cancer drugs for pulmonary hypertension

Acid pH enhances SARS-CoV-2 infection by up-regulating ACE2 receptor

Acid pH enhances SARS-CoV-2 infection by up-regulating ACE2 receptor

Study aims to elucidate the prevalence and etiology of PoPH in patients with chronic liver disease

Study aims to elucidate the prevalence and etiology of PoPH in patients with chronic liver disease

Algorithm accurately identifies pulmonary arterial hypertension in patients with scleroderma

Algorithm accurately identifies pulmonary arterial hypertension in patients with scleroderma

SARS-CoV-2 spike protein triggers cell signaling pathways in lung vascular cells

SARS-CoV-2 spike protein triggers cell signaling pathways in lung vascular cells

Virtual screening tool simplifies the process of diagnosing pulmonary hypertension

Virtual screening tool simplifies the process of diagnosing pulmonary hypertension

New approach to combination drug design could be applied to disease therapies beyond diabetes

New approach to combination drug design could be applied to disease therapies beyond diabetes

Researchers establish new 3D in vitro model for pulmonary arterial hypertension

Researchers establish new 3D in vitro model for pulmonary arterial hypertension

Fusion protein may help treat pulmonary arterial hypertension

Fusion protein may help treat pulmonary arterial hypertension

Molecular approach can improve diagnosis of pulmonary hypertension

Molecular approach can improve diagnosis of pulmonary hypertension

Sygnature Discovery supports New York Medical College pharmacologist in the fight against Covid-19

Sygnature Discovery supports New York Medical College pharmacologist in the fight against Covid-19

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection